Antimicrobial Susceptibility Testing Market is Predicted to Hit USD 4.7 Billion by 2030: Trends and Opportunities

The global antimicrobial susceptibility testing market was valued at $3,040.00 million in 2020, and is estimated to reach $4,736.03 million by 2030, growing at a CAGR of 5.8% from 2021 to 2030., driven by the increasing prevalence of antibiotic resistance and the need for effective treatment strategies.

CAGR: 5.8%
Current Market Size: USD 3.04 Billion
Forecast Growing Region: APAC
Largest Market: North America
Projection Time: 2021 - 2030
Base Year: 2021

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐇𝐞𝐫𝐞- https://www.alliedmarketresearch.com/request-sample/10647

𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬
Growing Prevalence of Antimicrobial Resistance: The increasing incidence of antimicrobial-resistant infections has heightened the importance of accurate and timely AST. As a result, there is a growing demand for advanced testing methods and technologies that can guide appropriate antibiotic therapy.

Advancements in Testing Technologies: The AST market has witnessed significant advancements in testing methodologies, including automated systems, molecular diagnostics, and rapid testing kits. These technologies offer faster and more precise results, enabling clinicians to make informed treatment decisions quickly.

Rise in Healthcare-Associated Infections (HAIs): HAIs remain a major concern for healthcare providers and governments worldwide. Effective AST plays a crucial role in controlling HAIs and reducing the burden of these infections, creating opportunities for AST market growth.

Increased Focus on Personalized Medicine: The concept of personalized medicine is gaining traction, and AST is a vital component in tailoring antibiotic treatments to individual patients. Advancements in genomics and precision medicine are driving the demand for more sophisticated AST solutions.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (273+ 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/antimicrobial-susceptibility-testing-market/purchase-options

Adoption of Point-of-Care Testing: Point-of-care AST systems have become increasingly popular as they offer rapid results directly at the patient's bedside. These systems help streamline patient care, reduce hospital stays, and improve antibiotic stewardship.

Rising Investments in Healthcare Infrastructure: Governments and private investors are recognizing the importance of strengthening healthcare infrastructure, including diagnostic capabilities. Increased investments in healthcare are likely to boost the AST market's growth.

Focus on Antifungal and Antiparasitic AST: While most AST research has focused on antibacterial agents, there is a growing need for improved testing methods for antifungals and antiparasitic drugs. The market for non-bacterial AST is expected to expand in response to this demand.

Adoption of AST in Veterinary Medicine: The issue of antimicrobial resistance is not limited to human health but also impacts veterinary medicine. As a result, there is a growing interest in AST for animals, presenting new opportunities for market players.

Collaborations and Partnerships: Companies in the AST market are increasingly forming collaborations and partnerships with research institutions and healthcare providers to enhance their product offerings and expand their market reach.

Emphasis on Regulatory Compliance: With the growing importance of AST in guiding treatment decisions, regulatory bodies are placing increased emphasis on ensuring the accuracy and quality of AST methods and results. Compliant testing solutions are likely to have a competitive advantage in the market.

𝐃𝐨 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 - https://www.alliedmarketresearch.com/purchase-enquiry/10647

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲
By product type, the manual segment was the highest contributor to the market in 2020.
On the basis of method type, the disk diffusion segment dominated the market in 2020
Depending on end user, the hospitals and diagnostic laboratories exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period.
Region wise, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

𝐊𝐞𝐲 𝐀𝐧𝐭𝐢𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐒𝐮𝐬𝐜𝐞𝐩𝐭𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬-
F. Hoffmann-La Roche AG
Bio-Rad Laboratories, Inc.
Compagnie Mérieux Alliance SAS (bioMérieux S.A.)
Becton, Dickinson, and Company
Merck KGaA (Millipore Sigma)
Thermo Fisher Scientific, Inc.
HiMedia Laboratories
Accelerate Diagnostics, Inc.
Danaher Corporation (Beckman Coulter Inc.)
Bruker Corporation

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞- https://www.alliedmarketresearch.com/autism-spectrum-disorders-market-A13338

𝐎𝐭𝐡𝐞𝐫 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲
𝐆𝐮𝐭𝐭𝐚-𝐏𝐞𝐫𝐜𝐡𝐚 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/gutta-percha-market-A24754

𝐂𝐞𝐧𝐭𝐫𝐚𝐥 𝐍𝐞𝐫𝐯𝐨𝐮𝐬 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/central-nervous-disorders-therapeutics-market-A13121

𝐃𝐞𝐧𝐭𝐚𝐥 𝐁𝐮𝐫𝐬 𝐚𝐧𝐝 𝐄𝐧𝐝𝐨𝐝𝐨𝐧𝐭𝐢𝐜 𝐦𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/dental-burs-and-endodontic-market-A11633

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.